Skip to main content
OpenTrials
Completed

NCT Number: NCT02002026

Uterine Artery Ligation to Decrease Blood Loss With Central Placenta Previa

This trial will address the effect of uterine artery ligation during Cesarean section in cases with placenta previa to decrease blood loss.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Placenta Previa Without Hemorrhage Female Urogenital Diseases and Pregnancy Complications Obstetric Labor Complications Placenta Diseases Placenta Previa Pregnancy Complications Urogenital Diseases

Age range

18 year–49 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Minia Maternity University Hospital

Minya, Minya Governorate, 61111, Egypt

About this study

This Study will address the effect of uterine artery ligation prior to fetal delivery during Cesarean section in cases with central placenta previa to guard against postpartum hemorrhage and to minimize blood loss.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Placenta previa is diagnosed when the lowest placental edge is located within 5 cm of the internal os at ultrasound
  • Symptomatic Placenta previa with at least one episode of bleeding
  • Estimated gestational age within 28 to 40 weeks
  • Maternal age > 18 years
  • Informed consent
  • Social affiliation

Exclusion criteria

  • Premature rupture of membranes
  • Severe bleeding.
  • Abnormal fetal heart rates.
  • Pre-eclampsia, chorioamnionitis, severe chronic renal disease.

Treatment and study plan

Uterine artery ligation

Procedure

Uterine artery ligation during cesarean section before delivery of the baby

Primary outcomes

  1. Changes in hemoglobin level

    Time frame: hemoglobin level will be done baseline and will be repeated 24 hours after delivery

    Changes in hemoglobin level before and after CS will reflect the amount of blood loss during operation

Secondary outcomes

  1. Degree of uterine contractility.

    Time frame: During CS and within 3 hours after CS

Sponsors and collaborators

Lead sponsor

Minia Maternity University Hospital

Other

Registry information

Official study title

Uterine Artery Ligation to Minimize Blood Loss in Patients With Central Placenta Previa

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Dec 5, 2013
Registry last updated
Mar 16, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.